PDB Short entry for 6G2N HEADER HYDROLASE 23-MAR-18 6G2N TITLE CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC 5'(3')-DEOXYRIBONUCLEOTIDASE IN TITLE 2 COMPLEX WITH THE INHIBITOR PB-PAU COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5'(3')-DEOXYRIBONUCLEOTIDASE, CYTOSOLIC TYPE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CYTOSOLIC 5',3'-PYRIMIDINE NUCLEOTIDASE,DEOXY-5'- COMPND 5 NUCLEOTIDASE 1,DNT-1; COMPND 6 EC: 3.1.3.-; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: CME IS BETA-MERCAPTO ETHANOL COVALENTLY BOUND TO COMPND 9 CYSTEIN RESIDUE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NT5C, DNT1, UMPH2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS 5'-NUCLEOTIDASE, DEPHOSPHORYLATION, PHOSPHORYLATION, HAD-LIKE, KEYWDS 2 MITOCHONDRIA, HYDROLASE-HYDROLASE INHIBITOR COMPLEX, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR P.PACHL,P.REZACOVA,J.BRYNDA REVDAT 3 17-JAN-24 6G2N 1 LINK REVDAT 2 06-FEB-19 6G2N 1 JRNL REVDAT 1 11-JUL-18 6G2N 0 JRNL AUTH P.PACHL,O.SIMAK,M.BUDESINSKY,J.BRYNDA,I.ROSENBERG,P.REZACOVA JRNL TITL STRUCTURE-BASED OPTIMIZATION OF BISPHOSPHONATE NUCLEOSIDE JRNL TITL 2 INHIBITORS OF HUMAN 5'(3')-DEOXYRIBONUCLEOTIDASES JRNL REF EUR.J.ORG.CHEM. 2018 JRNL REFN ISSN 1434-193X JRNL DOI 10.1002/EJOC.201800515 REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.41 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 88.0 REMARK 3 NUMBER OF REFLECTIONS : 66015 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.152 REMARK 3 R VALUE (WORKING SET) : 0.151 REMARK 3 FREE R VALUE : 0.192 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2100 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3127 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 291 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.42 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.41000 REMARK 3 B22 (A**2) : 1.70000 REMARK 3 B33 (A**2) : -1.32000 REMARK 3 B12 (A**2) : -1.14000 REMARK 3 B13 (A**2) : 0.09000 REMARK 3 B23 (A**2) : 0.22000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.071 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.066 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.063 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.966 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6G2N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-MAR-18. REMARK 100 THE DEPOSITION ID IS D_1200009327. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-NOV-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9184 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 68116 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 42.410 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.8 REMARK 200 DATA REDUNDANCY : 2.220 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 18.8400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.21 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4YIH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MORPHEUS H2, 0.1M MES/IMIDAZOLE PH REMARK 280 6.5, 10% PEG 8000, 20% ETHYLENE GLYCOL, 0.02M OF EACH AMINO ACID, REMARK 280 , PH 8, VAPOR DIFFUSION, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16990 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 ASN A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 SER A 5 REMARK 465 ALA A 6 REMARK 465 ARG A 7 REMARK 465 GLY A 200 REMARK 465 ALA A 201 REMARK 465 ALA A 202 REMARK 465 GLN A 203 REMARK 465 ARG A 204 REMARK 465 GLU A 205 REMARK 465 SER B 1 REMARK 465 ASN B 2 REMARK 465 ALA B 3 REMARK 465 ALA B 4 REMARK 465 SER B 5 REMARK 465 ALA B 6 REMARK 465 ARG B 7 REMARK 465 GLY B 200 REMARK 465 ALA B 201 REMARK 465 ALA B 202 REMARK 465 GLN B 203 REMARK 465 ARG B 204 REMARK 465 GLU B 205 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 33 NE CZ NH1 NH2 REMARK 470 GLU A 79 OE1 OE2 REMARK 470 LYS A 108 CG CD CE NZ REMARK 470 ARG A 154 CD NE CZ NH1 NH2 REMARK 470 GLU A 158 CG CD OE1 OE2 REMARK 470 CME A 170 CZ OH REMARK 470 ARG B 32 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 79 OE1 OE2 REMARK 470 LYS B 108 CD CE NZ REMARK 470 ARG B 118 CD NE CZ NH1 NH2 REMARK 470 ARG B 154 CD NE CZ NH1 NH2 REMARK 470 GLU B 158 CG CD OE1 OE2 REMARK 470 CME B 169 CZ OH REMARK 470 CME B 170 CE CZ OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 89 NE - CZ - NH2 ANGL. DEV. = -3.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 15 -67.08 -94.50 REMARK 500 VAL A 18 -52.21 -132.20 REMARK 500 MET B 15 -69.49 -92.07 REMARK 500 VAL B 18 -51.18 -131.65 REMARK 500 SER B 186 173.86 179.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 301 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 14 OD2 REMARK 620 2 ASP A 16 O 86.2 REMARK 620 3 ASP A 149 OD1 84.3 92.6 REMARK 620 4 O84 A 302 O11 89.1 91.4 172.1 REMARK 620 5 HOH A 408 O 89.9 174.6 90.8 84.8 REMARK 620 6 HOH A 409 O 168.4 87.4 86.4 100.6 97.1 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 301 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 14 OD2 REMARK 620 2 ASP B 16 O 86.3 REMARK 620 3 ASP B 149 OD1 85.1 94.7 REMARK 620 4 O84 B 302 O11 89.3 90.0 172.4 REMARK 620 5 HOH B 420 O 91.4 174.7 89.8 85.3 REMARK 620 6 HOH B 421 O 169.8 87.2 87.7 98.5 95.8 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue O84 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue O84 B 302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6G22 RELATED DB: PDB REMARK 900 SIMILAR PROTEIN WITH DIFFERENT LIGAND REMARK 900 RELATED ID: 6G2L RELATED DB: PDB REMARK 900 SIMILAR PROTEIN WITH DIFFERENT LIGAND REMARK 900 RELATED ID: 6G2M RELATED DB: PDB REMARK 900 SIMILAR PROTEIN WITH SAME LIGAND DBREF 6G2N A 6 205 UNP Q8TCD5 NT5C_HUMAN 2 201 DBREF 6G2N B 6 205 UNP Q8TCD5 NT5C_HUMAN 2 201 SEQADV 6G2N SER A 1 UNP Q8TCD5 EXPRESSION TAG SEQADV 6G2N ASN A 2 UNP Q8TCD5 EXPRESSION TAG SEQADV 6G2N ALA A 3 UNP Q8TCD5 EXPRESSION TAG SEQADV 6G2N ALA A 4 UNP Q8TCD5 EXPRESSION TAG SEQADV 6G2N SER A 5 UNP Q8TCD5 EXPRESSION TAG SEQADV 6G2N SER B 1 UNP Q8TCD5 EXPRESSION TAG SEQADV 6G2N ASN B 2 UNP Q8TCD5 EXPRESSION TAG SEQADV 6G2N ALA B 3 UNP Q8TCD5 EXPRESSION TAG SEQADV 6G2N ALA B 4 UNP Q8TCD5 EXPRESSION TAG SEQADV 6G2N SER B 5 UNP Q8TCD5 EXPRESSION TAG SEQRES 1 A 205 SER ASN ALA ALA SER ALA ARG SER VAL ARG VAL LEU VAL SEQRES 2 A 205 ASP MET ASP GLY VAL LEU ALA ASP PHE GLU ALA GLY LEU SEQRES 3 A 205 LEU ARG GLY PHE ARG ARG ARG PHE PRO GLU GLU PRO HIS SEQRES 4 A 205 VAL PRO LEU GLU GLN ARG ARG GLY PHE LEU ALA ARG GLU SEQRES 5 A 205 GLN TYR ARG ALA LEU ARG PRO ASP LEU ALA ASP LYS VAL SEQRES 6 A 205 ALA SER VAL TYR GLU ALA PRO GLY PHE PHE LEU ASP LEU SEQRES 7 A 205 GLU PRO ILE PRO GLY ALA LEU ASP ALA VAL ARG GLU MET SEQRES 8 A 205 ASN ASP LEU PRO ASP THR GLN VAL PHE ILE CYS THR SER SEQRES 9 A 205 PRO LEU LEU LYS TYR HIS HIS CYS VAL GLY GLU LYS TYR SEQRES 10 A 205 ARG TRP VAL GLU GLN HIS LEU GLY PRO GLN PHE VAL GLU SEQRES 11 A 205 ARG ILE ILE LEU THR ARG ASP LYS THR VAL VAL LEU GLY SEQRES 12 A 205 ASP LEU LEU ILE ASP ASP LYS ASP THR VAL ARG GLY GLN SEQRES 13 A 205 GLU GLU THR PRO SER TRP GLU HIS ILE LEU PHE THR CME SEQRES 14 A 205 CME HIS ASN ARG HIS LEU VAL LEU PRO PRO THR ARG ARG SEQRES 15 A 205 ARG LEU LEU SER TRP SER ASP ASN TRP ARG GLU ILE LEU SEQRES 16 A 205 ASP SER LYS ARG GLY ALA ALA GLN ARG GLU SEQRES 1 B 205 SER ASN ALA ALA SER ALA ARG SER VAL ARG VAL LEU VAL SEQRES 2 B 205 ASP MET ASP GLY VAL LEU ALA ASP PHE GLU ALA GLY LEU SEQRES 3 B 205 LEU ARG GLY PHE ARG ARG ARG PHE PRO GLU GLU PRO HIS SEQRES 4 B 205 VAL PRO LEU GLU GLN ARG ARG GLY PHE LEU ALA ARG GLU SEQRES 5 B 205 GLN TYR ARG ALA LEU ARG PRO ASP LEU ALA ASP LYS VAL SEQRES 6 B 205 ALA SER VAL TYR GLU ALA PRO GLY PHE PHE LEU ASP LEU SEQRES 7 B 205 GLU PRO ILE PRO GLY ALA LEU ASP ALA VAL ARG GLU MET SEQRES 8 B 205 ASN ASP LEU PRO ASP THR GLN VAL PHE ILE CYS THR SER SEQRES 9 B 205 PRO LEU LEU LYS TYR HIS HIS CYS VAL GLY GLU LYS TYR SEQRES 10 B 205 ARG TRP VAL GLU GLN HIS LEU GLY PRO GLN PHE VAL GLU SEQRES 11 B 205 ARG ILE ILE LEU THR ARG ASP LYS THR VAL VAL LEU GLY SEQRES 12 B 205 ASP LEU LEU ILE ASP ASP LYS ASP THR VAL ARG GLY GLN SEQRES 13 B 205 GLU GLU THR PRO SER TRP GLU HIS ILE LEU PHE THR CME SEQRES 14 B 205 CME HIS ASN ARG HIS LEU VAL LEU PRO PRO THR ARG ARG SEQRES 15 B 205 ARG LEU LEU SER TRP SER ASP ASN TRP ARG GLU ILE LEU SEQRES 16 B 205 ASP SER LYS ARG GLY ALA ALA GLN ARG GLU MODRES 6G2N CME A 169 CYS MODIFIED RESIDUE MODRES 6G2N CME A 170 CYS MODIFIED RESIDUE MODRES 6G2N CME B 169 CYS MODIFIED RESIDUE MODRES 6G2N CME B 170 CYS MODIFIED RESIDUE HET CME A 169 17 HET CME A 170 8 HET CME B 169 8 HET CME B 170 7 HET MG A 301 1 HET O84 A 302 34 HET MG B 301 1 HET O84 B 302 34 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM MG MAGNESIUM ION HETNAM O84 [(2~{R},4~{A}~{R},6~{R},7~{A}~{R})-6-[2,4- HETNAM 2 O84 BIS(OXIDANYLIDENE)-5-[(~{E})-3-PHOSPHONOPROP-1- HETNAM 3 O84 ENYL]PYRIMIDIN-1-YL]-2-PHENYL-4~{A},6,7,7~{A}- HETNAM 4 O84 TETRAHYDRO-4~{H}-FURO[3,2-D][1,3]DIOXIN-2- HETNAM 5 O84 YL]PHOSPHONIC ACID FORMUL 1 CME 4(C5 H11 N O3 S2) FORMUL 3 MG 2(MG 2+) FORMUL 4 O84 2(C19 H22 N2 O11 P2) FORMUL 7 HOH *291(H2 O) HELIX 1 AA1 ASP A 21 PHE A 34 1 14 HELIX 2 AA2 PRO A 41 ARG A 45 5 5 HELIX 3 AA3 LEU A 49 ARG A 58 1 10 HELIX 4 AA4 ASP A 60 GLU A 70 1 11 HELIX 5 AA5 GLY A 83 ASP A 93 1 11 HELIX 6 AA6 CYS A 112 GLY A 125 1 14 HELIX 7 AA7 GLY A 125 GLU A 130 1 6 HELIX 8 AA8 CME A 169 ARG A 173 5 5 HELIX 9 AA9 ASN A 190 SER A 197 1 8 HELIX 10 AB1 ASP B 21 PHE B 34 1 14 HELIX 11 AB2 PRO B 41 ARG B 45 5 5 HELIX 12 AB3 LEU B 49 ARG B 58 1 10 HELIX 13 AB4 ASP B 60 GLU B 70 1 11 HELIX 14 AB5 GLY B 83 LEU B 94 1 12 HELIX 15 AB6 CYS B 112 GLY B 125 1 14 HELIX 16 AB7 GLY B 125 GLU B 130 1 6 HELIX 17 AB8 ASP B 137 VAL B 141 5 5 HELIX 18 AB9 CME B 169 ARG B 173 5 5 HELIX 19 AC1 ASN B 190 SER B 197 1 8 SHEET 1 AA112 ARG A 182 LEU A 184 0 SHEET 2 AA112 GLU A 163 PHE A 167 1 N LEU A 166 O LEU A 184 SHEET 3 AA112 LEU A 145 ASP A 148 1 N LEU A 146 O ILE A 165 SHEET 4 AA112 VAL A 9 VAL A 13 1 N LEU A 12 O LEU A 145 SHEET 5 AA112 THR A 97 THR A 103 1 O GLN A 98 N VAL A 9 SHEET 6 AA112 ILE A 132 THR A 135 1 O ILE A 133 N ILE A 101 SHEET 7 AA112 ILE B 132 THR B 135 -1 O LEU B 134 N LEU A 134 SHEET 8 AA112 THR B 97 THR B 103 1 N ILE B 101 O ILE B 133 SHEET 9 AA112 VAL B 9 VAL B 13 1 N VAL B 11 O GLN B 98 SHEET 10 AA112 LEU B 145 ASP B 148 1 O LEU B 145 N LEU B 12 SHEET 11 AA112 GLU B 163 PHE B 167 1 O ILE B 165 N LEU B 146 SHEET 12 AA112 ARG B 182 LEU B 184 1 O LEU B 184 N LEU B 166 LINK C THR A 168 N CME A 169 1555 1555 1.33 LINK C CME A 169 N CME A 170 1555 1555 1.32 LINK C CME A 170 N HIS A 171 1555 1555 1.35 LINK C THR B 168 N CME B 169 1555 1555 1.35 LINK C CME B 169 N CME B 170 1555 1555 1.33 LINK C CME B 170 N HIS B 171 1555 1555 1.34 LINK OD2 ASP A 14 MG MG A 301 1555 1555 2.09 LINK O ASP A 16 MG MG A 301 1555 1555 2.10 LINK OD1 ASP A 149 MG MG A 301 1555 1555 2.07 LINK MG MG A 301 O11 O84 A 302 1555 1555 2.15 LINK MG MG A 301 O HOH A 408 1555 1555 2.09 LINK MG MG A 301 O HOH A 409 1555 1555 2.08 LINK OD2 ASP B 14 MG MG B 301 1555 1555 2.03 LINK O ASP B 16 MG MG B 301 1555 1555 2.10 LINK OD1 ASP B 149 MG MG B 301 1555 1555 2.04 LINK MG MG B 301 O11 O84 B 302 1555 1555 2.17 LINK MG MG B 301 O HOH B 420 1555 1555 2.10 LINK MG MG B 301 O HOH B 421 1555 1555 2.10 SITE 1 AC1 6 ASP A 14 ASP A 16 ASP A 149 O84 A 302 SITE 2 AC1 6 HOH A 408 HOH A 409 SITE 1 AC2 24 ASP A 14 ASP A 16 PHE A 22 PHE A 48 SITE 2 AC2 24 ALA A 50 TYR A 69 SER A 104 LEU A 106 SITE 3 AC2 24 LEU A 107 ARG A 136 LYS A 138 MG A 301 SITE 4 AC2 24 HOH A 402 HOH A 404 HOH A 406 HOH A 408 SITE 5 AC2 24 HOH A 409 HOH A 411 HOH A 419 HOH A 430 SITE 6 AC2 24 HOH A 442 HOH A 459 HOH A 490 HOH A 512 SITE 1 AC3 6 ASP B 14 ASP B 16 ASP B 149 O84 B 302 SITE 2 AC3 6 HOH B 420 HOH B 421 SITE 1 AC4 23 ASP B 14 ASP B 16 PHE B 22 PHE B 48 SITE 2 AC4 23 LEU B 49 ALA B 50 TYR B 69 SER B 104 SITE 3 AC4 23 PRO B 105 LEU B 106 LEU B 107 ARG B 136 SITE 4 AC4 23 LYS B 138 MG B 301 HOH B 403 HOH B 409 SITE 5 AC4 23 HOH B 411 HOH B 420 HOH B 421 HOH B 458 SITE 6 AC4 23 HOH B 465 HOH B 480 HOH B 492 CRYST1 38.877 47.231 61.795 67.86 88.69 77.37 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025722 -0.005762 0.001740 0.00000 SCALE2 0.000000 0.021697 -0.008946 0.00000 SCALE3 0.000000 0.000000 0.017509 0.00000